Epiaortic ultrasonography has high sensitivity for the detection of atherosclerosis. In several studies, the technique has identified atherosclerosis of the ascending aorta as the major risk factor ...

Late-phase trials of targeted therapies for elevated lipoprotein(a) are nearing completion, with the first readouts expected ...

JenaValve Technology, Inc., developer and manufacturer of the Trilogy® Transcatheter Heart Valve (THV) System, today announced the appointment of Maria Jose Arana as Vice President of Quality and ...

JenaValve Technology, Inc., developer and manufacturer of the Trilogy ® Transcatheter Heart Valve (THV) System, today announced the appointment of Edward (Ed) Sarnowski as Chief Technology Officer. Ed ...

Each year, we begin building the next edition of EuroPCR around September, always starting from the needs of the ...

Leaflet modification technique developed to prevent LVOT obstruction ...

The data reflect a high degree of technical success, clinical efficacy, and safety of the new technique, says Gennaro Giustino.

The Seismiq 4CE IVL catheter [Image courtesy of Boston Scientific] EuroPCR 2026 brought together a range of treatment developers across interventional cardiology in Paris last week. Technologies on ...

BACKGROUND: Congenital heart disease (CHD), the most common birth defect and a leading cause of infant mortality, is ...

I’m 70 years old, and my whole family is prone to edema, varicose veins and deep vein thrombosis due to venous insufficiency.

The Cardiovascular Research Foundation® (CRF®) announced the highly anticipated lineup of late-breaking research to be presented at New York Valves: The Structural Heart SummitTM. The premier ...

I read about a new treatment for Alzheimer’s disease called NeuralCIM from Cuba. Do you think this is real? — J.B.